IOVA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Iovance Biotherapeutics Inc

NASDAQ | IOVA

2.25

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$980.51M

Market Cap

-

P/E Ratio

-1.19

EPS

$9.38

52 Week High

$1.64

52 Week Low

HEALTHCARE

Sector

IOVA Chart

Recent Chart
Price Action

IOVA Technicals

Tags:

IOVA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $164M
Cost Of Revenue $124M
Costof Goods And Services Sold $124M
Operating Income -$395M
Selling General And Administrative $52M
Research And Development $282M
Operating Expenses $435M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $44M
Income Before Tax -$375M
Income Tax Expense -$2.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$372M
Comprehensive Income Net Of Tax -
Ebit -$395M
Ebitda -$352M
Net Income -$372M

Revenue & Profitability

Earnings Performance

IOVA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $910M
Total Current Assets $457M
Cash And Cash Equivalents At Carrying Value $116M
Cash And Short Term Investments $116M
Inventory $52M
Current Net Receivables $69M
Total Non Current Assets $453M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $282M
Intangible Assets Excluding Goodwill $282M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $208M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $200M
Total Current Liabilities $122M
Current Accounts Payable $28M
Deferred Revenue -
Current Debt -
Short Term Debt $13M
Total Non Current Liabilities $78M
Capital Lease Obligations $57M
Long Term Debt $1M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $58M
Other Current Liabilities $82M
Other Non Current Liabilities -
Total Shareholder Equity $710M
Treasury Stock -
Retained Earnings -$2.4B
Common Stock $13K
Common Stock Shares Outstanding $290M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$353M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $44M
Capital Expenditures $11M
Change In Receivables -
Change In Inventory -$40M
Profit Loss -
Cashflow From Investment -$96M
Cashflow From Financing $391M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$372M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $164M
Cost Of Revenue $124M
Costof Goods And Services Sold $124M
Operating Income -$395M
Selling General And Administrative $52M
Research And Development $282M
Operating Expenses $435M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $44M
Income Before Tax -$375M
Income Tax Expense -$2.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$372M
Comprehensive Income Net Of Tax -
Ebit -$395M
Ebitda -$352M
Net Income -$372M

IOVA News

IOVA Profile

Iovance Biotherapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Iovance Biotherapeutics, Inc. is a pioneering clinical-stage biotechnology firm based in San Carlos, California, specializing in innovative cancer immunotherapy through its proprietary tumor-infiltrating lymphocyte (TIL) therapy. This cutting-edge approach leverages the patient’s immune system to target and treat various malignancies, with a primary focus on melanoma and cervical cancer. With a promising pipeline and commitment to scientific excellence, Iovance is well-positioned to address significant unmet medical needs in oncology, making it an appealing investment in the expanding field of cancer therapeutics.

LPTX
+368.57%
$2.05
DRCT
+10.93%
$0.12
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
PAVS
-90.66%
$0.09
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
IVP
+2.98%
$0.12
ASST
-6.25%
$1.05
ADAP
-15.14%
$0.05
BITF
-6.75%
$3.24
PLUG
+1.51%
$2.01
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
INTC
-1.56%
$39.92
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
ADD
-25.47%
$0.05
NFE
+18.70%
$1.44
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
AHMA
+157.58%
$12.39
BMNR
-11.98%
$29.15
CNEY
-15.81%
$1.22
RPGL
+2.39%
$0.41
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
ONDS
-3.10%
$7.65
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
CLSK
-4.07%
$14.48
BYND
+2.87%
$1.01
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
SNAP
-0.60%
$7.63
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
AFMD
-34.94%
$0.18
F
+0.11%
$13.29
CIFR
-2.72%
$19.79
AMZN
+1.77%
$233.22
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
HOOD
-4.68%
$122.47
CAN
-6.65%
$0.94
MODV
-25.22%
$0.43
NCT
-29.38%
$0.54
BTBT
-7.14%
$2.20
BTG
-0.54%
$4.59
RIG
+0.80%
$4.44
RIVN
+2.72%
$17.32
DNN
+0.03%
$2.56
AMD
+0.47%
$218.57
T
+0.77%
$26.02
RUBI
-12.21%
$0.14
PLTR
-0.09%
$168.29
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
SHOT
-74.37%
$0.39
ORCL
-1.46%
$201.95
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
IBRX
-1.26%
$2.33
DVLT
-4.17%
$1.94
RGTI
-7.45%
$23.66
ITUB
-1.08%
$7.71
CPNG
-4.79%
$26.81
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
CRWV
+3.17%
$75.44
AAPL
+0.30%
$279.71
APLD
+3.21%
$27.97
GOOG
-0.68%
$317.92
DEFT
-12.82%
$1.32
BBWI
+9.60%
$19.08
TE
+9.58%
$4.51
LPTX
+368.57%
$2.05
DRCT
+10.93%
$0.12
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
PAVS
-90.66%
$0.09
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.59%
$179.83
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
FTEL
+54.11%
$1.31
IVP
+2.98%
$0.12
ASST
-6.25%
$1.05
ADAP
-15.14%
$0.05
BITF
-6.75%
$3.24
PLUG
+1.51%
$2.01
CHR
+4.09%
$0.04
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
INTC
-1.56%
$39.92
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
AAL
+0.12%
$14.06
ADD
-25.47%
$0.05
NFE
+18.70%
$1.44
SRM
+53.27%
$10.30
TLRY
-4.69%
$0.77
AHMA
+157.58%
$12.39
BMNR
-11.98%
$29.15
CNEY
-15.81%
$1.22
RPGL
+2.39%
$0.41
BMNU
-24.74%
$6.16
IRBT
+15.18%
$1.81
NIO
-5.90%
$5.17
ONDS
-3.10%
$7.65
TSLA
-0.28%
$428.92
YGMZ
+0.17%
$0.11
WLGS
-5.57%
$0.04
CLSK
-4.07%
$14.48
BYND
+2.87%
$1.01
MTSR
-0.35%
$70.50
SOFI
-1.05%
$29.40
SNAP
-0.60%
$7.63
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MARA
-6.26%
$11.07
PFE
-1.24%
$25.41
AFMD
-34.94%
$0.18
F
+0.11%
$13.29
CIFR
-2.72%
$19.79
AMZN
+1.77%
$233.22
NWTN
-9.09%
$0.70
AG
+12.73%
$15.23
IREN
-1.32%
$47.81
MSTR
-10.92%
$157.83
GRYP
-10.38%
$1.38
PRPH
-19.10%
$0.16
HOOD
-4.68%
$122.47
CAN
-6.65%
$0.94
MODV
-25.22%
$0.43
NCT
-29.38%
$0.54
BTBT
-7.14%
$2.20
BTG
-0.54%
$4.59
RIG
+0.80%
$4.44
RIVN
+2.72%
$17.32
DNN
+0.03%
$2.56
AMD
+0.47%
$218.57
T
+0.77%
$26.02
RUBI
-12.21%
$0.14
PLTR
-0.09%
$168.29
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
GOOGL
-0.82%
$317.54
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
EXK
-4.32%
$9.50
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
SHOT
-74.37%
$0.39
ORCL
-1.46%
$201.95
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
IBRX
-1.26%
$2.33
DVLT
-4.17%
$1.94
RGTI
-7.45%
$23.66
ITUB
-1.08%
$7.71
CPNG
-4.79%
$26.81
GPUS
-7.34%
$0.28
MU
+2.70%
$236.48
GRAB
-2.44%
$5.31
PLTD
+0.21%
$7.05
CRWV
+3.17%
$75.44
AAPL
+0.30%
$279.71
APLD
+3.21%
$27.97
GOOG
-0.68%
$317.92
DEFT
-12.82%
$1.32
BBWI
+9.60%
$19.08
TE
+9.58%
$4.51
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.